Biomedicines, 2022 · DOI: https://doi.org/10.3390/biomedicines10123186 · Published: December 8, 2022
Axons in the peripheral nervous system can repair themselves after damage, unlike those in the central nervous system. This difference is crucial in spinal cord, brain, and peripheral nerve injuries, where axonal regrowth is often disrupted. Intrinsic growth factors significantly aid axonal regeneration in injured nerves. Factors like protein profiles, microtubule stability, and signaling pathways distinguish the self-renewal capacity of central versus peripheral axons. However, glial scar development, myelin-associated inhibitors, insufficient neurotrophic factors, and inflammatory reactions hinder axonal regeneration. This review explores these mechanisms and potential therapeutic targets to promote quicker axonal healing.
Identified signalling molecules like cAMP, STAT3, AKT, and BDNF can serve as therapeutic targets to restore function in injured axons.
Downregulating GSK-3β, PTEN, and SOCS3 and myelin-associated inhibitors can modify the fate of regenerating axons.
Developing valid and affordable clinical approaches is crucial for functional axon recovery.